NCT00940225 2024-04-25Study of Cabozantinib (XL184) in Adults With Advanced MalignanciesExelixisPhase 2 Completed730 enrolled 25 charts
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled